Latest Breaking News On - Regina hartfield - Page 1 : comparemela.com

Health Matters: FDA Approves Groundbreaking Gene-Editing Tool That Could Cure Sickle Cell Disease

More Americans could have access to a life-changing treatment, but it comes at an expensive price point per patient.

FDA approves world-first gene editing treatment: Sickle cell therapy gives hope to 100,000 Americans with incurable disease - but it'll cost millions of dollars per DOSE

In a ground-breaking decision, the Food and Drug Administration approved the first gene therapies to treat people with sickle cell disease

Sickle Cell Disease Association of America Inc. statement about gene therapy approval

bluebird bio (BLUE) Announces FDA Approval of LYFGENIA for Patients Ages 12 and Older with Sickle Cell Disease and a History of Vaso-Occlusive Events

Bluebird bio Announces FDA Approval of LYFGENIA™ (lovotibeglogene autotemcel) for Patients Ages 12 and Older with Sickle Cell Disease and a History of Vaso-Occlusive Events

Severe vaso-occlusive events were eliminated for 94% of evaluable patients and all VOEs were eliminated for 88% of evaluable patients between 6 and 18 months post-infusion LYFGENIA is the most.